Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02831348 · ClinicalTrials.gov registry record
Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases
A clinical trial of Asthma and Cystic Fibrosis, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 59
- Enrollment target
- 1
- Study location
NCT02831348: Completed study of Asthma and Cystic Fibrosis, sponsored by Boston Children's Hospital.
NCT02831348 is a study of Asthma and Cystic Fibrosis that has completed, run by Boston Children's Hospital. The registered enrollment target is 59 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02831348, a study of Asthma and Cystic Fibrosis, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot cross-sectional study of measured transcutaneous CO-oximetry in children with inflammatory and non-inflammatory conditions.
Primary Outcome
A pairwise comparison of mean SpCO will be performed between asthma exacerbation group and each other group, e.g., asthma exacerbation v. stable asthma, asthma exacerbation v. pneumonia, etc. An independent t-test will be used to determine statistical significance of the difference of means.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-12 |
What the finished NCT02831348 record still lists
NCT02831348 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT02831348 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02831348 about?
NCT02831348 is a clinical study titled "Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases". This is a pilot cross-sectional study of measured transcutaneous CO-oximetry in children with inflammatory and non-inflammatory conditions.
What is the current status of trial NCT02831348?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2015-10. Estimated completion is 2021-12.
What conditions does trial NCT02831348 study?
This clinical trial studies the following conditions: Asthma, Cystic Fibrosis, Pneumonia, Allergic Rhinitis.
Who is sponsoring clinical trial NCT02831348?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02831348 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02831348's enrollment target sits among peer trials
59 255th of 374 higher than 120 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia